There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Devi Sridhar and colleagues discuss how three major trends in global governance, the
rise of emerging economies, the increase in multi-bi financing and institutional proliferation,
have ramifications for whether NCDs will be included in the post-2015 Sustainable
Development Goals agenda.
Please see later in the article for the Editors' Summary
Since 2000, the emergence of several large disease-specific global health initiatives (GHIs) has changed the way in which international donors provide assistance for public health. Some critics have claimed that these initiatives burden health systems that are already fragile in countries with few resources, whereas others have asserted that weak health systems prevent progress in meeting disease-specific targets. So far, most of the evidence for this debate has been provided by speculation and anecdotes. We use a review and analysis of existing data, and 15 new studies that were submitted to WHO for the purpose of writing this Report to describe the complex nature of the interplay between country health systems and GHIs. We suggest that this Report provides the most detailed compilation of published and emerging evidence so far, and provides a basis for identification of the ways in which GHIs and health systems can interact to mutually reinforce their effects. On the basis of the findings, we make some general recommendations and identify a series of action points for international partners, governments, and other stakeholders that will help ensure that investments in GHIs and country health systems can fulfil their potential to produce comprehensive and lasting results in disease-specific work, and advance the general public health agenda. The target date for achievement of the health-related Millennium Development Goals is drawing close, and the economic downturn threatens to undermine the improvements in health outcomes that have been achieved in the past few years. If adjustments to the interactions between GHIs and country health systems will improve efficiency, equity, value for money, and outcomes in global public health, then these opportunities should not be missed.
Summary Background Ministers of health, donor agencies, philanthropists, and international agencies will meet at Bamako, Mali, in November, 2008, to review global priorities for health research. These individuals and organisations previously set health priorities for WHO, either through its regular budget or extra-budgetary funds. We asked what insights can be gained as to their priorities from previous decisions within the context of WHO. Methods We compared the WHO biennial budgetary allocations with the burden of disease from 1994–95 to 2008–09. We obtained data from publicly available WHO sources and examined whether WHO allocations varied with the burden of disease (defined by death and disability-adjusted life years) by comparing two WHO regions—Western Pacific and Africa—that are at differing stages of epidemiological transition. We further assessed whether the allocations differed on the basis of the source of funds (assessed and voluntary contributions) and the mechanism for deciding how funds were spent. Findings We noted that WHO budget allocations were heavily skewed toward infectious diseases. In 2006–07, WHO allocated 87% of its total budget to infectious diseases, 12% to non-communicable diseases, and less than 1% to injuries and violence. We recorded a similar distribution of funding in Africa, where nearly three-quarters of mortality is from infectious disease, and in Western Pacific, where three-quarters of mortality is from non-communicable disease. In both regions, injuries received only 1% of total resources. The skew towards infectious diseases was substantially greater for the WHO extra-budget, which is allocated by donors and has risen greatly in recent years, than for the WHO regular budget, which is decided on by member states through democratic mechanisms and has been held at zero nominal growth. Interpretation Decision makers at Bamako should consider the implications of the present misalignment of global health priorities and disease burden for health research worldwide. Funds allocated by external donors substantially differ from those allocated by WHO member states. The meeting at Bamako provides an opportunity to consider how this disparity might be addressed. Funding None.
As part of a cluster of articles critically reflecting on the theme of “no health without research,” Devi Sridhar discusses a major challenge in the governance of research funding: “multi-bi” financing that allows the priorities of funding bodies to dictate what health issues and diseases are studied.
The authors have declared no competing interest exists.
Wrote the first draft of the manuscript: DS. Contributed to the writing of the manuscript:
DS CEB SD JE LOG PH MM.
ICMJE criteria for authorship read and met: DS CEB SD JE LOG PH MM. Agree with manuscript
results and conclusions: DS CEB SD JE LOG PH MM.
The Policy Forum allows health policy makers around the world to discuss challenges
and opportunities for improving health care in their societies.
Article
Publisher ID:
PMEDICINE-D-13-01036
DOI: 10.1371/journal.pmed.1001487
PMC ID: 3720248
PubMed ID: 23935458
SO-VID: 3665bfcd-2e22-4455-aedb-3bfe57822c29
Copyright statement:
Copyright @
2013
License:
This is an open-access article distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are credited.
History
Page count
Pages: 6
Funding
Go4Health is a research project funded by the European Union's Seventh Framework Program,
grant HEALTH-F1-2012-305240, and by the Australian Government's NH&MRC-European Union
Collaborative Research Grants, grant 1055138. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.